Trial intelligence / Profile preview

Lacosamide in Pediatric Focal Epilepsy (Long-term Safety/PK)

CTR20170053Phase 2Completed

Sponsor
UCB
Start
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lacosamide in epilepsy, sponsored by UCB. Started Apr 2018; status: completed.

02

Drugs

lacosamide
03

Conditions

epilepsy

Beyond the preview

Go deeper on CTR20170053.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20170053.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call